Izumo, Former VP of Novartis Institutes for BioMedical Research, Appointed Head of Takeda’s MD Drug Discovery Unit

Takeda Pharmaceutical announced on August 27 that Seigo Izumo, M.D., who has extensive experience in the area of cardiovascular diseases, took on the same day the post of Head of the company’s Metabolic Diseases Drug Discovery Unit, Pharmaceutical Research Division...read more